Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Thomas Mehrling

Thomas Mehrling

CEO, Mundipharma EDO GmbH, Switzerland Swaziland

Giuseppe Leone

Giuseppe Leone

Catholic University, Italy Italy

Jan Jacques Michiels

Jan Jacques Michiels

Goodheart Institute & Foundation in Nature Medicine & Health,Netherlands Netherlands

Francesco Piazza

Francesco Piazza

Padua University School of Medicine,Italy Italy

David J. Bearss

David J. Bearss

CEO, Tolero Pharmaceuticals, USA USA

Saad Kenderian

Saad Kenderian

Mayo Clinic,USA USA

Steven L Warner

Steven L Warner

Tolero Pharmaceuticals, Inc., USA USA

Alaa Alyahyawi

Alaa Alyahyawi

Queen Mary University of London, UK UK

Hematologic Oncology 2017

Sessions/Tracks

1.Hematology 2017.2.Hematology conferences.3.Blood Disorders. 4.Hematologic Oncology conferences.5.Hematology Events. 6.Blood transplantation.7.Blood Congress 2017.8.Hemato immunology. 9.Hematology Conferences.10.Hemato Oncology conferences Nevada. 11. Hematologic Hematology Conferences. 12. Blood Cancer Conferences.13.Hematology Conference.14.Leukemia conferences 2017.15.Hemotologic Oncology Conference.16.Blood Disorder Conferences Barcelona Spain Europe Worldwide Events USA ConferenceSeries Ltd 17.Hematologic Oncology 2017 18.Hematology meetings 19.Hematologists 2017 20.Hematology conference UK.21.Hematology conference Barcelona 22.Hematology event.23.Hematology event Europe.24.Oncology conferences 25.Cancer conferences 26.Oncologists conferences 27.Oncology meetings 28.Oncology events 29.Cancer events.30.Cancer conferences 2017 31.Oncologists conferences 2017.32.Oncology conferences.33.AmericaCancer conferences.34.Europe Oncology Conferences.35.Middle Blood cancer conferences.36.Hematology and Oncology events.37.Blood malignancies conferences.38.leukaemia conferences.39.conferences Haematologic Oncology 40.American Society of Hematology conferences.41.Blood malignancy symptoms conferences London meeting 2017.42. ESH.43.European School of Haematology. 44.Oncology. 45.Cancer. 46.Cancer Causes and Preventions. 47.Cancer Diagnosis and Diagnostics. 48.Cancer Treatment and Therapeutics. 49.Cancer and Pharmacology. 50.Biomarkers. 51.Hematology. 52.Oncology. 52.Blood Cancer Causes and Symptoms. 53.Blood Cancer Diagnosis and Treatment. 54.Bone Marrow Transplantation. 55.Hematological Malignancies Prognosis. 56.Blood Disorders. 57.Immunology. 58.Cancer Epidemiology. 59.Case Report. 60.Entrepreneurs Investment Meet. 61.Hematology. 62.Hematologic Oncology. 63.Hematological Disorders. 64.Blood Disorders. 65.Hematology Research. 66.Blood Disease Condition and Treatment. 67.Hematology Diagnosis. 68.Hematology and Nursing. 69.Hematology and Pharma industry. 70.Veterinary Hematology. 71.Blood Transplantation. 72.Diagnosis In Blood Disorder. 73.Immunology. 74.Blood Based Products. 75.Various Aspects of Hematology. 76.New Drug Discovery in Hematology. 77.Hematology Case Report. 78.Entrepreneurs Investment Meet. 79.Leukemia. 80.Hemotology. 81.Hematologic-oncology. 81.Blood Disorders and Blood oncology. 82.Leukemia immunology. 83.Hemato Immunology &Stem Cell Research. 84.Cancer and Alternative Medicine. 85.Haematological malignancies. 86.Haematological malignancies: Prognosis. 87.Biomarkers. 88.Bone Marrow Transplantation and surgery. 89.Advance in Bone Marrow Transplantation. 90.Hematologic Disorders. 91.Immunohematology. 92.Hematology and Oncology. 93.Blood Disorders Diagnosis and Treatment. 94.Clinical and Experimental Hematology. 95.Hematopathology. 96.Pediatric Hematology. 97.Hematology Nursing. 98.Pharmaceutical Hematology. 99.Stem Cell Research. 100.Hematology Market. 101.Novel Discoveries in Hematology. 102.Clinical trials. 103.Haematology Case reports and Epidemiology. 104.Entrepreneurs Investment Meet. 105.Oncology. 106.Clinical Oncology. 107.Pediatric Oncology. 108.Radiation Oncology. 109.Chemotherapy. 110.Oncologists. 111.Organ Specific Cancer. 112.Cancer Causes. 113.Cancer Diagnostics and Staging. 114.Cancer Treatment and Therapy. 115.Cancer Biomarkers. 116.Cancer and Pharmacology. 117.Cancer Vaccines and Prevention. 118.Cancer Prognosis. 119.Cancer and Alternative Medicine. 120. Economic Impact on Cancer. 121.Oncology Case reports. 122.Cancer Nursing and Care. 123.Oncogenomics & Oncoproteomics 124.Cancer Pharma Industry 125.Comprehensive Geriatric Oncology 126.World Cancer Market 127.Entreprenuers Investment Meet 128.leukemia symptoms 129.leukemia treatment 130.leukemia rash 131.leukemia awareness 132.Adult leukemia patients 133.leukemia cells vs normal cells 134.cancer patients 135.leukemia ribbon 136.leukemia statistics 137.leukemia cancer patients 138.lymphoma 139.leukemia in adults 140.chemotherapy for leukemia 141.leukemia bruises 142.leukemia and lymphoma society 143.leukemia and smoking 144.leukemia and lymphoma research uk 145.leukemia and myeloma research uk 146.leukaemia and lymphoma 147.leukemia and thrombocytopenia 148.leukemia and sore throat 149.leukemia adults. 150.Leukemia and Lymphoma Society.

ConferenceSeries Ltd invites all the participants from all over the world to attend 9th International Conference on Leukemia and Hematologic Oncology’ during October 05-06, 2017 in London,UK. The conference will be organized around the theme “Exploring latest Innovations and Interactive discussions on Leukemia and Hematologic Oncology care"

Hematologic Oncology 2017 welcomes haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

     Key Topics of Hematologic Oncology 2017

Leukemia

 

Hematology

 

Hematologic-oncology

 

Blood Disorders and Blood oncology

 

Leukemia immunology

 

Hemato Immunology &Stem Cell Research

 

Cancer and Alternative Medicine

 

Haematological malignancies

 

Haematological malignancies: Prognosis

 

Biomarkers

 

Bone Marrow Transplantation and surgery

 

Advance in Bone Marrow Transplantation

 

Acute promyelocytic leukemia

Stem cell transplants

Hematologic Oncology

 

Hematologic Disorders

 

Immunohematology

 

Hematology and Oncology

 

Blood Disorders  Diagnosis & Treatment

 

Clinical and Experimental Hematology

 

Hematopathology

 

Pediatric Hematology

 

Veterinary Hematology

 

Hematology Nursing

 

Oncology

 

Cancer

Cancer Causes and Preventions

 

Cancer Diagnosis and Diagnostics

 

Cancer Treatment and Therapeutics

 

Cancer and Pharmacology

 

Targeted therapies

Blood Cancer Diagnosis & Treatment

 

Bone Marrow Transplantation

 

Blood Cancer: Causes & Symptoms

 

Immunology

 

Hematology  Case Report

 

Hematological Malignancies: Prognosis

 

Cancer Epidemiology

 

Entrepreneurs Investment Meet

 

Hematology Research

 

Hematological Disorders

 

Blood Disease Condition and Treatment

Blood Disorders

 

Hematology and Nursing

 

Hematology and Pharma industry

 

Hematology Diagnosis

 

Blood Transplantation

 

 

Diagnosis In Blood Disorder

 

Chemotherapy

Blood Based Products

 

Various Aspects of Hematology

 

Hematology : Case Report

 

Pharmaceutical Hematology

 

Hematology Market

 

Stem Cell Research

 

Clinical trials

 

Case reports and Epidemiology

Novel Discoveries in Hematology

 

Blood and Bone Cancer

Cancer Therapy

Nursing Oncology

Oncology Market Access and Pricing

Hemolytic uremic syndrome

 

Thrombocytosis

Hemophillia

Myelodysplastic syndrome

 

Leukemia in adults

Chemotherapy for leukemia

Leukemia statistics

leukemia and lymphoma society

 

Leukemia cancer patients

Leukemia awareness

blood cells

leukemia symptoms

 

leukemia treatment

 

leukemia rash

 

leukemia awareness

 

adult leukemia patients

 

leukemia cells vs normal cells

 

cancer patients

 

leukemia ribbon

 

 

 

Track 1. Leukemia

       Leukaemia is a malignancy (cancer) of blood cells. In leukemia, abnormal blood cells are produced in the bone marrow. Leukemia involves the production of abnormal white blood cells the cells responsible for struggling infection. The abnormal cells in leukemia not function in the same way as normal white blood cells. The leukemia cells continue to develop and divide, finally crowding out the normal blood cells. The end result is that it becomes tough for the body to fight infections, control haemorrhage, and carriage oxygen.

Related Conferences

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event)  October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 2Hematology

Erythrocytes are also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of haemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the W.B.C (leucocytes) act as the defending cells in protecting the immune system from the foreign cells. Formation of blood cellular components are called as Hematopoiesis and all the cellular blood components are derived from hematopoiesis stem cells in a healthy individual nearly 1011–1012  new blood cells are produced these help in steady peripheral circulation. If there is a increases of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA. Society of  Hematologic Oncology, USA. American society clinical oncology, USA. Advanced Practitioner Society for Hematology and Oncology, New Jersey. American Society of Pediatric Hematology/Oncology, Chicago, USA. Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA. The Canadian hematology society , CANADA. The British Society for Haematology, England. Albanian National Society of Hematology and Transfusiology, Albania. Austrian Society of Hematology and Oncology, Austria.Czech Society of Hematology, Czech Republic. German Society of Hematology, Germany Hematological Society of Iceland , Iceland. Turkish Society of Hematology ,Turkey.

Track 3.Hematologic-oncology

Hematologic Oncology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of etiologist involves treating diseases that affect the production of blood and its components, such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Haematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by haematology. A few of these different types of blood conditions that are looked at include anemia, haemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed

Related Conferences:

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA. Society of  Hematologic Oncology, USA. American society clinical oncology, USA. Advanced Practitioner Society for Hematology and Oncology, New Jersey. American Society of Pediatric Hematology/Oncology, Chicago, USA. Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA. The Canadian hematology society , CANADA.;The British Society for Haematology, England. Albanian National Society of Hematology and Transfusiology, Albania. ; Austrian Society of Hematology and Oncology, Austria.Czech Society of Hematology, Czech Republic. German Society of Hematology, Germany Hematological Society of Iceland , Iceland. Turkish Society of Hematology ,Turkey;

Track 4. Blood Disorders and Blood oncology

Anemia is the most common type of blood disorder we treat. Patients with anemia have a deficiency of oxygen-rich red blood cells or their red blood cells do not function properly. A low level of hemoglobin, the iron-rich protein that carries the oxygen in red blood cells, signals the condition. Anemia can be chronic, or a temporary condition caused by other health issues, including cancer treatment, hepatitis C, and HIV/AIDS. Anemia frequently remains undiagnosed because it is an underlying condition of other health issues, including cancer, cardiovascular disease, diabetes, HIV/AIDS, inflammatory bowel disease, chronic kidney disease, and rheumatoid arthritis. Hemophilia is a rare, typically inherited blood disorder in which the blood does not properly clot and causes excessive bleeding, which can cause damage to organs, joints, and tissues. Patient may suffer excessive bleeding from the site of an injury or from internal bleeding. Clotting Disorders Hematologists also treat conditions related to the proteins that trigger bleeding and clotting, including thrombosis (clotting) and hemostasis (bleeding). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 5. Leukemia immunology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumor marker-based diagnostic tests. 

Related Conferences:

 Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

 Track 6. Hemato Immunology &Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 7.Cancer and Alternative Medicine

Ayurvedic medicine is an ancient Indian system of medicine which began about 5,000 years ago. It is not just one treatment. It is a way of diagnosing illness and using a wide range of treatments and techniques. Herbal medicine uses plants, or mixtures of plant extracts, to treat illness and promote health. It aims to restore your body's ability to protect, regulate and heal itself. It is a whole body approach, so looks at your physical, mental and emotional well-being. It is sometimes called phytomedicine, phytotherapy or botanical medicine. Naturopathic doctors (NDs) believe that cancer arises from an imbalance that causes a systemic breakdown within the body. Homeopathy is based on the theory of treating like with like. So to treat an illness a homeopathic therapist (homeopath) uses tiny doses of a substance that in large doses would actually cause the symptoms of the illness.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 8. Haematological malignancies

Hematologic malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes.Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera  and myelofibrosis . This scientific session will focus on all types of common or rare blood cancers such as acute promyelocytic leukemia (APL) and chronic myelomonocytic leukemia hairy cell leukemia (HCL), large granular lymphocytic leukemia (LGL), t-cell acute lymphoblastic leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative diseases.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 9.Haematological malignancies: Prognosis

The estimate of how the disease will go for a patient is called prognosis. There are many factors affect prognosis that include: the type of cancer and where it is in the body, the stage of the cancer, the cancer’s grade. Grade provides clues about how quickly the cancer is likely to grow and spread certain traits of the cancer cells, the age and how healthy body was before cancer & how successful is the treatment.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 10. Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

Track 11.Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells. Bone marrow is a spongy tissue found in the hollow centres of some bones. It contains specialist stem cells, which produce the body's blood cells.

A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass.Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

 Track 12.Advance in Bone Marrow Transplantation

An increasing number of diseases may be treated successfully by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell series or product is replaced, it has now become routine treatment for many forms of leukemia where the transplant provides the rescue after lethal marrow ablation. Recently, diseases such as thalassemia and other inherited metabolic diseases have also been treated by BMT. Formerly the problems of BMT were mainly concerned with graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was usually fatal. Since the development of techniques for T cell removal the incidence of GVHD has greatly diminished. T cell removal has also allowed HLA haploidentical mismatched grafts to be performed successfully for immunodeficiency, but there is still a high graft rejection rate in leukemia. 

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Related Societies : The American Society of Hematology, USA.; Society of  Hematologic Oncology, USA. American society clinical oncology, USA;Advanced Practitioner Society for Hematology and Oncology, New Jersey; American Society of Pediatric Hematology/Oncology, Chicago, USA; Ohio Hematology Oncology Society, Ohio. International Society for Experimental Hematology, USA; The Canadian hematology society , CANADA;. The British Society for Haematology, England; Albanian National Society of Hematology and Transfusiology, Albania; Austrian Society of Hematology and Oncology, Austria; Czech Society of Hematology, Czech Republic; German Society of Hematology, Germany ; Hematological Society of Iceland , Iceland; Turkish Society of Hematology ,Turkey;

 

 

About conference

ConferenceSeries Ltd invites all the participants across the globe to attend the "9th International Conference on Leukemia and Hematologic Oncology” (Hematologic Oncology 2017) slated on October 05-06, 2017, London,UK

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Hematologic Oncology 2017 will focus the latest and exciting innovations in allied areas of Leukemia and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. When you have leukemia, the bone marrow starts to make a lot of abnormal white blood cells, called leukemia cells. An estimated combined total of 156,420 people are expected to be diagnosed with leukemia in 2014. New cases of leukemia are expected to account for 9.4 percent of the estimated 1,665,540 new cancer cases diagnosed in 2014. 

ConferenceSeries Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Why to attend?

With members from around the world focused on learning about Leukemia and Hematologic Oncology; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Leukemia diagnosis, treatment and surgery involved are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event

Target Audience:

Haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from Academia and Research along with the industrial professionals from biomedical companies and healthcare sectors.

Welcome Messages

Market Analysis

Hematologic Oncology 2017 welcomes attendees, presenters, delegates and exhibitors etc. from the globe to London, UK. We are delighted to invite you all to attend and register for the “9th International conference on Leukemia and Hematologic Oncology” which is going to be held during October 05-06, 2017 at London,UK

For more details please visit: http://leukemia.conferenceseries.com/

Importance & Scope

Hematologic Oncology 2017 will be the best platform for all the haematologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Hematologic Oncology and treatment. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability, and quality of life.

Experts will explain how a new generation of treatment options gives patients new hope in the fight against Leukemia and Hematologic Oncology.

Geographically, the global Leukemia and Hematologic Oncology  treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa .North America takes the largest share of global Hematologic Oncology  treatment market followed by Europe. The global Leukemia and Hematologic Oncology treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research.

Region wise scope of Research in percentage

Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-71550.jpg.pagespeed.ic.nVI2T--spG.webp

Why London?

London is the capital and most populous city of England and the United Kingdom with resident population of 7,375, making it the smallest city in England. Standing on the River Thames, London has been a major settlement for two millennia. It’s a city where old and new amiably clash, high culture rubs shoulders with pearly queens – with its streets paved with regal glory.

London is a leading global city, with strengths of heritage, arts, commerce, education, entertainment, fashion, finance, research and development, healthcare, media, professional services and tourism. In UK more than 80 Universities/ colleges, 145 pharmaceutical companies, and more than 60 Associations and societies are working on Hemophilia and other blood related disorders. Funding grants by the government of china for research nearly 200 million USD$ to universities and 1.5 billion USD$ to the pharmaceutical and research institutes.

Conference Highlights:

Why to attend..??

This unique international conference provides a platform for researchers and decision makers in cancer research to present their latest findings and learn about all the important developments in cancer research. Many scientists and world's renowned experts will participate in the conference. Throughout the course of the three day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate cancer research communities.

Target Audience

Hematologic Oncology 2017 welcomes the haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

  Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-63921.jpg.pagespeed.ic.be0E434nrV.webp

Major Associations

In London

Children with Cancer UK

Children’s Cancer and Leukaemia Group

United Kingdom Association of Cancer Registries

Leukemia Cancer Society

Cancer Research UK

Lymphoma Association

Leukaemia & Lymphoma Research

Myeloma UK

Leukaemia CARE

In USA

American Cancer Society (ACS)

Lymphoma Research Foundation, USA

Hematology/Oncology Pharmacy Association

National Cancer Institute

National Children’s Leukaemia Foundation, USA

Cancer Research Institute, USA

International Myeloma Foundation

National Cancer Institute (USA)

Association of International Cancer Research

National Children's Leukemia Foundation

Cancer and Leukemia Group B

International Agency for Research on Cancer (IARC)

Childhood Leukemia Foundation

American Society of Haematology

Union for International Cancer Control (UICC)

Prevent Cancer Foundation

American Childhood Cancer Organisation

American Association for Cancer Research (AACR)

Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-46646.jpg.pagespeed.ic.qKBU4UwTP0.webp

 

 Worldwide

International Fanconi Anemia Registry (IFAR)

Union for International Cancer Control

The Leukaemia and Lymphoma Society of Canada

Cancer Research UK

Indian Association of blood cancer & Allied Diseases

Leukaemia Cancer Society

Armenian Association of Hematology & Oncology

Leukaemia & Blood Cancer New Zealand

Korean Cancer Association

Fanconi Anaemia Australia

Leukaemia Foundation of Australia

Cancer Association of South Africa

Indian Cancer Society

Brazilian Lymphoma & Leukaemia Association

Chronic Myelogenous Leukaemia Society of Canada

Children’s Cancer and Leukaemia Group

Chinese Society of Clinical Oncology

German Cancer Society

Canadian Cancer Sociey

Lymphoma Foundation Canada

Cancer Society of Finland

France Lymphoma Hope

Society for Paediatric Oncology & Hematology

Leukaemia &Blood Cancer, New Zealand

Medical Oncology Group of Australia

Australian & New Zealand Children’s Hematology/Oncology Group

Childhood Cancer Research Group, UK

National Cancer Institute of Argentina

Cancer Society Nepal

Top Universities

In London

University of Oxford

UCL Medical School

University of Cambridge

King's College London

Queen Mary, University of London

Imperial College, London

Institute on Cancer Research

St. George’s, University of London

The University of Sheffield

Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-66780.jpg.pagespeed.ic.AQcNxmaXBi.webp

 

In USA

Harvard University

Mayo Medical School, US

Stanford University

Cambridge University

Yale University

University of Colorado

St. George’s University

 Emory University

John Hopkins University

University of Maryland, Baltimore

University of California

North-western University, IIlinois

University of Texas

Massachusetts Institute of Technology (MIT)

Indiana University School of Medicine, Melvin and Bren Simon Cancer Center,

University of Rochester, New York

Carnegie Mellon University, United States of America

University of Pennsylvania, Philadelphia

Cornell University, United States of America

Baylor COLLEGE of medicine US

Princeton University, US

University of Minnesota Medical Center

University of Auckland-

University of Michigan

University of Melbourne

Columbia University, New York

University of Iowa

Ohio State University, Columbus

Rockefeller University, US

 Worldwide

University of Toronto, Canada

Thomas Jefferson University

University of Chicago, Chicago

University of Wisconsin, Madison-

Washington University in St. Louis

University of Tokoyo, Japan

National University of Singapore (NUS), Singapore 

Guangxi Medical University, Nanning, China

Indianapolis University “La Sapienza” of Rome, Rome, Italy 

University of Lyon, France

University Of Leeds 

University Of Queensland,Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

 University of Southampton

University of Pittsburgh

 McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

University of Alberta

University Of British Columbia 

University Of Leicester 

 University Of Chester

University of Kentucky

University of north Durham

 University Of Surrey

 University Of Edinburgh

 University of Glasgow

 University Of Bordeaux,France

Oregon Health and Science University

 Knight Cancer Institute

Loyola University Chicago

University oF Louisville

 University of Toledo

Rutgers University

University Of Calgary

University Of Witaterstrand

University Of Western Sydney, Australia

University of Melbourne

University Of South Australia

University Of New South Wales

Monash University, Australia

University of Milan, Italy

Kyoto University, Japan

The University of Auckland, NZ

University Of Zurich

National Taiwan University 

The University of Manchester, UK

Ichan School of medicine, Mount Sinai

Pondicherry University, India

University of phoenix

Griffith University

University Of Exeter

Crimea State Medical University,Ukriane

 Heidelberg University

 Hackensack University Medical Center

 Kyoto University, Taiwan

 Osaka University, Japan

 Kursk State Medical University, Russia 

Companies

Roche group is one of the leading providers of leukemia and Hematologic Oncology treatment drugs. Some of the key players in leukemia and hematologic oncology  treatment market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Johnson & Johnson Pvt. Ltd., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Bayer AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd.

Market Analysis report

The market of hematological malignancies is expressed to show steady growth rate during the forecast period from 2014 – 2020. This growth is driven by major factors, such as rising prevalence of various diseases and extensive R&D practices are ongoing across the globe to bring new and more effective drugs and formulations in the market. 

Advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to keep up the growth of global blood cancer treatment market. However, divergent nature of blood cancers and increasing stringency in the regulatory requirements are some of the major restraints limiting the growth of global blood cancer treatment market.

       Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-78623.jpg.pagespeed.ic.HP_iGO-zh3.webp

The global market for Hematological cancer drugs was estimated to be $18.7 billion in 2012.  By 2017, the market is expected to reach $28.8 billion, growing at a CAGR of 9% between 2012 and 2017.The total global market for hematological disorder drugs and diagnostics in 2012 was estimated at nearly $72.9 billion.  By 2017, the market is expected to reach $99.1 billion, growing at a compound annual growth rate (CAGR) of 6.4% between 2012 and 2017.  The global blood disorders market segment is estimated at $49.3 billion in 2012 and is expected to reach nearly $64.7 billion by 2017.  The major reason for the low growth rate is the expected decline in the annual cost of treating blood disorders and the patent expirations of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, all these drugs together brought revenue of about $32 billion into the global blood disorders market.)

Description: http://bloodmalignancies.conferenceseries.com/upload-images/xbloodmalignancies2017_-56044.jpg.pagespeed.ic.cD-4CRhVFR.webp

 

Past Conference Report

Hematologic Oncology 2016

The International conference on leukemia and Hematologic Oncology convoked by Conference Series LLC during October17-18, 2016 was successfully held at Rome, Italy with a theme “Solution Eradicate to Hematologic Oncology” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Thanks to all our momentous speakers, conference attendees who contributed towards the successful run of the conference.

Hematologic Oncology 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Leukemia, Hematologic Oncology, Haematology, Paediatric and Hematologic Oncology.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

·         Leukemia

·         Hemotology

·         Hematologic-oncology

·         Oncology

·         Paediatric Oncology

·         Clinical Oncology

·         Oncologists

·         Blood Disorders and Blood oncology

·         Leukemia Causes and symptoms

·         Leukemia Pathophysiology

·         Leukemia risk factors

·         Leukemia:Staging

·         Leukemia: Diagnosis

·         Leukemia immunology

·         Oncology Case Report

·         Hemato Immunology &Stem Cell Research

·         Cancer and pharmacology

·         Cancer: Treatment and Therapy

·         Cancer :Diagnostics and Staging

·         Cancer and Alternative Medicine

·         Haematological malignancies

·         Haematological malignancies: Prognosis

·         Childhood Hematological Cancers

·         Biomarkers

·         Leukemia :Treatments and care

·         Bone Marrow Transplantation and surgery

·         Advance in Bone Marrow Transplantation

·         Cancer Clinical Trials

Hematologic Oncology 2016 Organizing Committee would like to thank the Moderator of the conference, Jan Jacques Michiels, Goodheart Institute & Foundation in Nature Medicine & Health,Netherlands, who has contributed a lot for the smooth functioning of this event.

Our special thanks to David J Bearss, Tolero Pharmaceuticals, USA for his special participation as Key Note Speaker titled “Sequential treatment of AML patients with Alvocidib followed by Cytarabine and Mitoxantrone is highly effective through a mechanism dependent on MCL1 expression and function” which marked the special attraction at the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Symposium and Special sessions:

Chronic lymphocytic leukemia: Risk factors and complications & The Diagnostic and prognostic value of CD38 and CD49d Expressions in chronic lymphocytic leukemia- Olfat M Hendy, Menoufia University, Egypt.

Diagnosis and treatment of DVT and prevention of DVT recurrence and the PTS: Bridging the gap between DVT and PTS in the primary care setting or outpatient ward - Jan Jacques Michiels, Good heart Institute, Netherlands.

Inhibition of AXL kinase reverses the mesenchymal phenotype in leukemia cells through the disruption of retinoic acid signalling - Steven L. Warner, Tolero Pharmaceuticals, Inc., USA

Conference Series LLC is privileged to felicitate Hematologic Oncology 2016 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. Conference Series LLC would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Hematologic Oncology.

With the valuable feedback received from the participants of Hematologic Oncology 2016,Conference Series LLC is glad to announce the commencement of “11th International conference on leukemia and Hematologic Oncology  during December 04-05, 2017 Madrid, Spain. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing Leukemia and Hematologic Oncology and its concomitant risk factors.

Let us meet again @ Hematologic Oncology 2017

 


Past Reports  Gallery  

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Hematology & Thromboembolic diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner